Nothing Special   »   [go: up one dir, main page]

Almizraq et al., 2018 - Google Patents

Characteristics of extracellular vesicles in red blood concentrates change with storage time and blood manufacturing method

Almizraq et al., 2018

View PDF
Document ID
525611723202984920
Author
Almizraq R
Holovati J
Acker J
Publication year
Publication venue
Transfusion Medicine and Hemotherapy

External Links

Snippet

Summary Background: Extracellular vesicles (EVs) in blood products are potential effectors of inflammation and coagulation after transfusion. The aim of this study was to assess the impact of different blood manufacturing methods and duration of hypothermic storage on the …
Continue reading at karger.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N2015/0065—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging

Similar Documents

Publication Publication Date Title
Almizraq et al. Characteristics of extracellular vesicles in red blood concentrates change with storage time and blood manufacturing method
Almizraq et al. Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity
Stroncek et al. Platelet transfusions
Gamonet et al. Processing methods and storage duration impact extracellular vesicle counts in red blood cell units
Wannez et al. Extracellular vesicles in red blood cell concentrates: an overview
Noulsri et al. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures
US20070259330A1 (en) Separation of cells
Dijkstra‐Tiekstra et al. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters
Masse Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process
Acker et al. Screening of red blood cells for extracellular vesicle content as a product quality indicator
Greening et al. Preparation of platelet concentrates for research and transfusion purposes
Donati et al. Detecting autologous blood transfusion in doping control: biomarkers of blood aging and storage measured by flow cytofluorimetry
Plaza et al. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system
Bianchi et al. Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation
Vucic et al. Evaluation of platelet activation in leukocyte-depleted platelet concentrates during storage
Green et al. Modern banking, collection, compatibility testing and storage of blood and blood components
Solheim et al. Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
Van Der Meer et al. WBC‐reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures
Kamel et al. Effects of storage time and leucocyte burden of packed and buffy-coat depleted red blood cell units on red cell storage lesion
Kumar et al. Leucodepletion and blood products
Alberts et al. In vitro evaluation of the Fresenius Kabi CATSmart autotransfusion system
Johnson et al. Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow‐fibre separation system
Cid et al. Automated preparation of whole blood–derived platelets suspended in two different platelet additive solutions and stored for 7 days
Shukla et al. Time dependent release of interleukin-8 and tumor necrosis factor-α in platelet concentrate
Greening et al. Preparation of platelet concentrates